These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 26835788)
1. The Promising Nanocarrier for Doxorubicin and siRNA Co-delivery by PDMAEMA-based Amphiphilic Nanomicelles. Cheng Q; Du L; Meng L; Han S; Wei T; Wang X; Wu Y; Song X; Zhou J; Zheng S; Huang Y; Liang XJ; Cao H; Dong A; Liang Z ACS Appl Mater Interfaces; 2016 Feb; 8(7):4347-56. PubMed ID: 26835788 [TBL] [Abstract][Full Text] [Related]
2. Comb-like amphiphilic polypeptide-based copolymer nanomicelles for co-delivery of doxorubicin and P-gp siRNA into MCF-7 cells. Suo A; Qian J; Zhang Y; Liu R; Xu W; Wang H Mater Sci Eng C Mater Biol Appl; 2016 May; 62():564-73. PubMed ID: 26952460 [TBL] [Abstract][Full Text] [Related]
3. Co-delivery of doxorubicin and siRNA by a simplified platform with oligodeoxynucleotides as a drug carrier. Liu T; Wang M; Wang T; Yao Y; Zhang N Colloids Surf B Biointerfaces; 2015 Feb; 126():531-40. PubMed ID: 25618822 [TBL] [Abstract][Full Text] [Related]
4. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles. Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793 [TBL] [Abstract][Full Text] [Related]
5. pH-responsive DNA nanomicelles for chemo-gene synergetic therapy of anaplastic large cell lymphoma. Li Y; Yue S; Cao J; Zhu C; Wang Y; Hai X; Song W; Bi S Theranostics; 2020; 10(18):8250-8263. PubMed ID: 32724469 [TBL] [Abstract][Full Text] [Related]
6. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer. Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487 [TBL] [Abstract][Full Text] [Related]
7. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells. Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420 [TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy. Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784 [TBL] [Abstract][Full Text] [Related]
9. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery. Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742 [TBL] [Abstract][Full Text] [Related]
10. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer. Wen ZM; Jie J; Zhang Y; Liu H; Peng LP Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938 [TBL] [Abstract][Full Text] [Related]
11. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy. Chen L; Ji F; Bao Y; Xia J; Guo L; Wang J; Li Y Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):418-429. PubMed ID: 27770912 [TBL] [Abstract][Full Text] [Related]
12. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin. Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896 [TBL] [Abstract][Full Text] [Related]
13. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery. Liu P; Yu H; Sun Y; Zhu M; Duan Y Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800 [TBL] [Abstract][Full Text] [Related]
14. Low-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapy. Zhu QL; Zhou Y; Guan M; Zhou XF; Yang SD; Liu Y; Chen WL; Zhang CG; Yuan ZQ; Liu C; Zhu AJ; Zhang XN Biomaterials; 2014 Jul; 35(22):5965-76. PubMed ID: 24768047 [TBL] [Abstract][Full Text] [Related]
15. Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex. Han M; Lv Q; Tang XJ; Hu YL; Xu DH; Li FZ; Liang WQ; Gao JQ J Control Release; 2012 Oct; 163(2):136-44. PubMed ID: 22940126 [TBL] [Abstract][Full Text] [Related]
16. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059 [TBL] [Abstract][Full Text] [Related]
17. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. Zhu C; Jung S; Luo S; Meng F; Zhu X; Park TG; Zhong Z Biomaterials; 2010 Mar; 31(8):2408-16. PubMed ID: 19963269 [TBL] [Abstract][Full Text] [Related]
18. In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas. Amjad MW; Amin MC; Katas H; Butt AM; Kesharwani P; Iyer AK Mol Pharm; 2015 Dec; 12(12):4247-58. PubMed ID: 26567518 [TBL] [Abstract][Full Text] [Related]
19. Synergistic gene and drug tumor therapy using a chimeric peptide. Han K; Chen S; Chen WH; Lei Q; Liu Y; Zhuo RX; Zhang XZ Biomaterials; 2013 Jun; 34(19):4680-9. PubMed ID: 23537665 [TBL] [Abstract][Full Text] [Related]
20. Nanoscaled poly(L-glutamic acid)/doxorubicin-amphiphile complex as pH-responsive drug delivery system for effective treatment of nonsmall cell lung cancer. Li M; Song W; Tang Z; Lv S; Lin L; Sun H; Li Q; Yang Y; Hong H; Chen X ACS Appl Mater Interfaces; 2013 Mar; 5(5):1781-92. PubMed ID: 23410916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]